Relationship between fibrinolytic and metabolic variables: a study in patients attending a lipid clinic

Ann Med. 2000 Mar;32(2):134-41. doi: 10.3109/07853890009011763.

Abstract

We investigated the relationship between plasma levels of metabolic and fibrinolytic variables in 163 fasted patients attending a lipid clinic. Of these patients, 118 had hypertriglyceridaemia (HTG) and 45 had normotriglyceridaemia (NTG). In HTG, basal fibrinolytic activity, ie tissue plasminogen activator (t-PA) activity, was impaired as a result of high plasminogen activator inhibitor type 1 (PAI-1) antigen and activity. Multiple stepwise regression analysis identified insulin and triglyceride levels as independent determinants of plasma PAI-1 levels (R2 = 0.18; P = 0.0001). When the patients were stratified into tertiles according to their levels of triglyceride and insulin, PAI-1 antigen levels were found to increase with rising levels of triglyceride in each insulin tertile. In contrast, the increase of PAI-1 with rising insulin levels was evident in the highest triglyceride tertile. In addition, subjects in the lowest tertile of both triglyceride and insulin had the lowest PAI-1 antigen levels, and subjects in the highest tertile of both triglyceride and insulin had the highest levels of PAI-1. Both basal and stimulated levels of t-PA antigen were significantly higher in HTG than in NTG. Multiple stepwise regression analysis identified triglyceride level as the sole major determinant of t-PA antigen levels (R2 = 0.13; P = 0.00003). The observation that both insulin and triglycerides correlate with PAI-1, whereas triglycerides were involved only in the increased secretion of t-PA, suggests that these two proteins are regulated by different mechanisms.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Ambulatory Care Facilities
  • Female
  • Humans
  • Hyperlipidemias / blood*
  • Hyperlipidemias / diagnosis
  • Hyperlipidemias / therapy
  • Insulin / biosynthesis*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Plasminogen Activator Inhibitor 1 / blood*
  • Plasminogen Activators / blood*
  • Reference Values
  • Regression Analysis
  • Sensitivity and Specificity
  • Tissue Plasminogen Activator / blood*
  • Triglycerides / biosynthesis*

Substances

  • Insulin
  • Plasminogen Activator Inhibitor 1
  • Triglycerides
  • Plasminogen Activators
  • Tissue Plasminogen Activator